Common use of Formation and Composition Clause in Contracts

Formation and Composition. As soon as reasonably possible and in any event within […***…] after the Effective Date, Adaptimmune and Bellicum shall establish a joint steering committee (the “JSC”) to monitor and coordinate the communication and activities of both Parties under this Agreement. The JSC shall be composed of at least […***…] but no more than […***…] representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the stage of development or commercialisation applicable, in terms of their seniority, decision-making authority, availability, function in their respective organizations, training and experience. Each Party may replace its JSC representatives from time to time upon written notice to the other Party; provided, however, if a Party’s JSC representative is unable to attend a JSC meeting, such Party may designate an alternate to attend such JSC meeting by providing notification in writing to the other Party’s Alliance Manager and following provision of such written notification the alternate will be entitled to perform the functions of such JSC representative at such JSC meeting. The Alliance Managers may attend meetings of the JSC but shall have no right to vote on any decisions of the JSC.

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)

Formation and Composition. As soon as reasonably possible and in any event within […***…] * after the Effective Date, Adaptimmune and Bellicum shall establish a joint steering committee (the “JSC”) to monitor and coordinate the communication and activities of both Parties under this Agreement. The JSC shall be composed of at least […***…] * but no more than […***…] * representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the stage of development or commercialisation applicable, in terms of their seniority, decision-making authority, availability, function in their respective organizations, training and experience. Each Party may replace its JSC representatives from time to time upon written notice to the other Party; provided, however, if a Party’s JSC representative is unable to attend a JSC meeting, such Party may designate an alternate to attend such JSC meeting by providing notification in writing to the other Party’s Alliance Manager and following provision of such written notification the alternate will be entitled to perform the functions of such JSC representative at such JSC meeting. The Alliance Managers may attend meetings of the JSC but shall have no right to vote on any decisions of the JSC.

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)

Formation and Composition. As soon as reasonably possible and in after Acceptance Date for any event within […***…] after the Effective DateTarget, Adaptimmune and Bellicum Noile-Immune shall establish a joint steering development committee (the “JSCJPT”) to monitor and coordinate the communication and activities of both Parties under this Agreementthe applicable Research Plan for the Nominated Target. The JSC JPT shall be composed of at least […***…] two (2) but no more than […***…] three (3) representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of development or commercialisation applicableresearch, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party may replace its JSC JPT representatives from time to time upon written notice to the Alliance Manager of the other Party; provided, however, if a Party’s JSC JPT representative is unable to attend a JSC JPT meeting, such Party may designate an alternate to attend such JSC JPT meeting by providing notification in writing to the other Party’s Alliance Manager and following provision of such written notification the alternate will be entitled to perform the functions of such JSC JPT representative at such JSC JPT meeting. The Alliance Managers may attend meetings of the JSC JPT but shall have no right to vote on any decisions of the JSCJPT.

Appears in 1 contract

Sources: Collaboration Agreement (Adaptimmune Therapeutics PLC)

Formation and Composition. As soon as reasonably possible and in any event within […after ***…] after the Effective Date* , Adaptimmune and Bellicum shall establish a joint steering development committee (the “JSCJDC”) to monitor and coordinate the communication and activities of both Parties under this Agreementeach Co-Development Plan. The JSC JDC shall be composed of at least […***…] * but no more than […***…] * representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of research, pre-clinical development or commercialisation applicableclinical development, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party may replace its JSC JDC representatives from time to time upon written notice to the Alliance Manager of the other Party; provided, however, if a Party’s JSC JDC representative is unable to attend a JSC JDC meeting, such Party may designate an alternate to attend such JSC JDC meeting by providing notification in writing to the other Party’s Alliance Manager and following provision of such written notification the alternate will be entitled to perform the functions of such JSC JDC representative at such JSC JDC meeting. The Alliance Managers may attend meetings of the JSC JDC but shall have no right to vote on any decisions of the JSCJDC.

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)

Formation and Composition. As soon as reasonably possible and in any event within after […***…] after the Effective Date], Adaptimmune and Bellicum shall establish a joint steering development committee (the “JSCJDC”) to monitor and coordinate the communication and activities of both Parties under this Agreementeach Co-Development Plan. The JSC JDC shall be composed of at least […***…] but no more than […***…] representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of research, pre-clinical development or commercialisation applicableclinical development, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party may replace its JSC JDC representatives from time to time upon written notice to the Alliance Manager of the other Party; provided, however, if a Party’s JSC JDC representative is unable to attend a JSC JDC meeting, such Party may designate an alternate to attend such JSC JDC meeting by providing notification in writing to the other Party’s Alliance Manager and following provision of such written notification the alternate will be entitled to perform the functions of such JSC JDC representative at such JSC JDC meeting. The Alliance Managers may attend meetings of the JSC JDC but shall have no right to vote on any decisions of the JSC.JDC. 132265684 v23 Page 15

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)

Formation and Composition. As Following [***], as soon as reasonably possible and in any event within […***…] after days thereafter, the Effective Date, Adaptimmune and Bellicum Parties shall establish a joint steering development committee (the “JSCJDC”) ), which will serve as a forum for the exchange of information with respect to monitor and coordinate the communication and activities Development of both Parties under this Agreementthe Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effect. The JSC JDC shall be composed of at least […***…] but no more than […***…] representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the stage of development or commercialisation applicable, in terms of their seniority, decision-making authority, availability, function in their respective organizations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JSC representatives from time to time upon written notice to by informing the other Party’s Alliance Manager in writing (which may be by email); provided, however, that if a Party’s JSC representative is unable to attend a JSC meeting, such Party may designate an alternate to attend such JSC meeting by providing notification in writing to informing the other Party’s Alliance Manager in writing (which may be by email) in advance and following provision submission of such written notification the alternate will be entitled to perform the functions of such JSC representative at such JSC meetingrepresentative. The Alliance Managers may attend meetings of the JSC but shall have no right to vote on any decisions of the JSCJDC.

Appears in 1 contract

Sources: Strategic Collaboration and License Agreement (Adaptimmune Therapeutics PLC)